Aydin, S. Et Al. 2011. To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?. Metabolism: Clinical and Experimental , vol.60, no.7 .

Aydin, S., ŞAHİN, İ., Demirel, U., & Aksoy, A., (2011). To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?. Metabolism: Clinical and Experimental , vol.60, no.7.

Aydin, Suleyman Et Al. "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?," Metabolism: Clinical and Experimental , vol.60, no.7, 2011

Aydin, Suleyman Et Al. "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?." Metabolism: Clinical and Experimental , vol.60, no.7, 2011

Aydin, S. Et Al. (2011) . "To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?." Metabolism: Clinical and Experimental , vol.60, no.7.

@article{article, author={Suleyman Aydin Et Al. }, title={To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?}, journal={Metabolism: Clinical and Experimental}, year=2011}